6p22

A chromosome band present on 6p
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Chromosome 6p22 was identified recently as a neuroblastoma susceptibility locus, but its mechanistic contributions to… (More)
  • table 1
Is this relevant?
Highly Cited
2014
Highly Cited
2014
Neuroblastoma is an embryonal tumor of the sympathetic nervous system and the most common extracranial tumor of childhood. By… (More)
  • figure 1
  • figure 2
  • figure 4
  • figure 5
  • figure 6
Is this relevant?
Highly Cited
2012
Highly Cited
2012
Obesity is a disorder with a complex genetic etiology, and its epidemic is a worldwide problem. Although multiple genetic loci… (More)
  • table 1
  • figure 1
  • figure 2
Is this relevant?
Highly Cited
2009
Highly Cited
2009
We conducted a SNP-based genome-wide association study (GWAS) focused on the high-risk subset of neuroblastoma. As our previous… (More)
  • figure 1
  • figure 2
Is this relevant?
Highly Cited
2006
Highly Cited
2006
To identify gene(s) targeted by 6p22 genomic gain, present in more than 50% retinoblastoma tumors, we used real-time RT-PCR to… (More)
Is this relevant?
Highly Cited
2006
Highly Cited
2006
Dyslexia is one of the most prevalent childhood cognitive disorders, affecting approximately 5% of school-age children. We have… (More)
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2005
Highly Cited
2005
DYX2 on 6p22 is the most replicated reading disability (RD) locus. By saturating a previously identified peak of association with… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2004
Highly Cited
2004
We demonstrate that, in human bladder cancer, amplification of the E2F3 gene, located at 6p22, is associated with overexpression… (More)
  • figure 1
  • figure 3
  • figure 2
Is this relevant?
2004
2004
Metaphase-based comparative genomic hybridization (CGH) has identified recurrent regions of gain on different chromosomes in… (More)
Is this relevant?